Short time to progression under first-line chemotherapy is a negative prognostic factor for time to progression and residual survival under second-line chemotherapy in advanced pancreatic cancer. [electronic resource]
Producer: 20080801Description: 335-9 p. digitalISSN:- 1423-0232
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Capecitabine
- Cohort Studies
- Deoxycytidine -- administration & dosage
- Disease Progression
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Humans
- Male
- Middle Aged
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Palliative Care
- Pancreatic Neoplasms -- drug therapy
- Prognosis
- Survival Rate
- Time Factors
- Gemcitabine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.